FROM PERTH TO PROVIDENCE: VEINTECH’S JOURNEY FROM LOCAL INNOVATION TO GLOBAL EXPANSION

Born in Western Australia, and now scaling in Rhode Island, US, VeinTech’s journey from Perth Biodesign’s 2019 Flagship Program to establishing a global presence shows how strategic partnerships can accelerate global expansion.

In 2025, the company became the first beneficiary of the Perth Biodesign–New England Medical Innovation Center (NEMIC) BioBridge, securing USD $750,000 in non-dilutive funding from the Rhode Island Life Science Hub to support US expansion.

Click here to read about VeinTech’s inspiring story.